Tender notice
NHS Framework Agreement for Branded Pharmaceuticals for London - Tranche B and Interim Biosimilars for Midlands & East, North of England and South of England
Notice details
- Published
- Category
- Not specified
- Buyer region
- North West
- Source
- View official notice
Public buyer
Public buyer
NHS EnglandTender value£710,890,000
- Planned startAs published in the notice
- Planned endAs published in the notice
Work description
NHS Framework Agreement for Branded Pharmaceuticals for London - Tranche B and Interim Biosimilars for Midlands & East, North of England and South of England
Offer reference number: CM/PHR/14/5446
Period of framework agreement: CM/PHR/14/5446/01 - 1 September 2017 - 31 August 2019 with an option to extend for up to 24 months
CM/PHR/14/5446/02 - North of England 1September 2017 - 28 February 2018 with an option to extend for up to 6 months South of England - 1 September 2017 - 31 August 2018 with an option to extend for up to 12 months Midlands and East - 1 September 2017 - 28 February 2019 with an option to extend for up to 18 months
Additional information: The procurement exercise is being conducted on the NHS England eTendering portal at www.nhsengland.bravosolution.co.uk the project code is tender_616 and the ITT code is itt_285. This is where the ITO documents are available.